The 19th century was an absolutely electrifying era, including in a literal sense. Although the phenomenon of electricity had ...

Lithium-ion batteries in personal electronic devices (PEDs) such as laptops, smartphones, powerbanks and electronic cigarettes can pose a serious safety risk in air travel. Damaged or overheated ...

In this guide, we'll walk through everything you need to know to build the best sim racing setup for your budget. You'll find tips on what to consider before purchasing your setup, detailed breakdowns ...

Geofence searches allow law enforcement to find suspects and witnesses by sweeping up location data from cellphone users near crime scenes. By Ann E. Marimow Reporting from Washington When the Call ...

As the four Artemis II astronauts looped around the moon this week before their return trip to Earth, so did four transparent chips, each about the size of a USB thumb drive and seeded with their bone ...

Today's nearly $70 billion U.S. biofuels economy is powered by two technology toolboxes. Biochemical technologies—used to produce around 17 billion gallons of ethanol annually—leverage microorganisms ...

Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology. “We are very ...

Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and ...

Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and ...

Ms. Lacks’s family accused Novartis of profiting from her cells, which were taken from her without her consent in 1951, when she was dying of cervical cancer. By Michael Levenson The pharmaceutical ...

Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells have already transformed the treatment of blood cancers. Yet, despite their ...